Related Experiment Video
Updated: Jan 8, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
The effect of hepatic steatosis index on prediabetes: A large-scale retrospective cohort study
Xiaohang Huang1, Haohan Zhai2, Xintao Zhang3
1Department of Traditional Chinese Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China.
Abstract:
The Hepatic Steatosis Index (HSI) is a well-established metric for evaluating hepatic fat accumulation. Although prior studies have examined the effect of HSI on diabetes, its association with prediabetes remains incompletely delineated. This study aims to elucidate the effect of HSI on prediabetes within a Chinese population. We conducted a multicenter cohort analysis involving 75,750 baseline normoglycemic adults from the Rich Healthcare Group in China. To assess the effect of HSI on prediabetes, this study employed Cox proportional hazards regression, restricted cubic spline models, subgroups, and sensitivity analyses. Multivariable-adjusted models identified HSI as an independent predictor of prediabetes (HR: 1.06, 95% CI: 1.04-1.07 for females, HR: 1.04, 95% CI: 1.03-1.05 for males). A nonlinear relationship between HSI and prediabetes risk was observed in both sexes, with an inflection point at 36.48 for females and 31.27 for males. Among females, a significant positive link with prediabetes emerged below the threshold of 36.48 (HR: 1.08, 95% CI: 1.06-1.10, P < 0.0001), while above this level the association was attenuated and failed to reach statistical significance (HR: 1.00, 95% CI: 0.97-1.02, P = 0.7579). In contrast, hazard ratios for males were 1.02 (95% CI: 1.00-1.04) below and 1.04 (95% CI: 1.03-1.05) above their respective inflection point. Our analysis revealed a non-linear positive correlation between HSI and prediabetes across both sexes. Precise assessment of HSI facilitates early identification of subjects at heightened risk, thereby enabling the implementation of targeted preventive strategies.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

